- Home
- CTSO vs PPSI Comparison
CTSO vs PPSI Comparison
Compare CTSO & PPSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTSO
- PPSI
- Stock Information
- Founded
- CTSO 1997
- PPSI 2008
- Country
- CTSO United States
- PPSI United States
- Employees
- CTSO N/A
- PPSI N/A
- Industry
- CTSO Medical/Dental Instruments
- PPSI Electrical Products
- Sector
- CTSO Health Care
- PPSI Industrials
- Exchange
- CTSO Nasdaq
- PPSI Nasdaq
- Market Cap
- CTSO 45.3M
- PPSI 40.4M
- IPO Year
- CTSO N/A
- PPSI N/A
- Fundamental
- Price
- CTSO $0.64
- PPSI $3.41
- Analyst Decision
- CTSO Buy
- PPSI Strong Buy
- Analyst Count
- CTSO 2
- PPSI 1
- Target Price
- CTSO $5.38
- PPSI $12.00
- AVG Volume (30 Days)
- CTSO 106.4K
- PPSI 103.6K
- Earning Date
- CTSO 11-13-2025
- PPSI 11-13-2025
- Dividend Yield
- CTSO N/A
- PPSI 43.60%
- EPS Growth
- CTSO N/A
- PPSI N/A
- EPS
- CTSO N/A
- PPSI 2.86
- Revenue
- CTSO $36,979,520.00
- PPSI $31,751,000.00
- Revenue This Year
- CTSO $11.93
- PPSI $27.32
- Revenue Next Year
- CTSO $21.22
- PPSI $16.14
- P/E Ratio
- CTSO N/A
- PPSI $1.20
- Revenue Growth
- CTSO 20.75
- PPSI 105.82
- 52 Week Low
- CTSO $0.60
- PPSI $2.25
- 52 Week High
- CTSO $1.61
- PPSI $6.53
- Technical
- Relative Strength Index (RSI)
- CTSO 24.35
- PPSI 31.55
- Support Level
- CTSO $0.60
- PPSI $3.80
- Resistance Level
- CTSO $0.70
- PPSI $4.49
- Average True Range (ATR)
- CTSO 0.06
- PPSI 0.29
- MACD
- CTSO -0.01
- PPSI -0.11
- Stochastic Oscillator
- CTSO 5.54
- PPSI 11.76
About CTSO Cytosorbents Corporation
CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.
About PPSI Pioneer Power Solutions Inc.
Pioneer Power Solutions Inc designs, manufactures, integrates, services, and sells distributed energy resources, on-site and mobile power generation equipment, and a platform of mobile electric vehicle (EV) charging solutions.. Its principal products and services include custom-engineered electrical transformers, switchgear and engine-generator sets and controls, complemented by a national field-service network to maintain and repair power generation assets.